Experimental design and analysis and their reporting II: Updated and simplified guidance for authors and peer reviewers MJ Curtis, S Alexander, G Cirino, JR Docherty, CH George, MA Giembycz, ... British journal of pharmacology 175 (7), 987-993, 2018 | 1289 | 2018 |
Experimental design and analysis and their reporting: new guidance for publication in BJP MJ Curtis, RA Bond, D Spina, A Ahluwalia, SPA Alexander, MA Giembycz, ... British journal of pharmacology 172 (14), 3461, 2015 | 1133 | 2015 |
Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology SPH Alexander, RE Roberts, BRS Broughton, CG Sobey, CH George, ... British journal of pharmacology 175 (3), 407, 2018 | 628 | 2018 |
Pharmacology of the eosinophil MA Giembycz, MA Lindsay Pharmacological reviews 51 (2), 213-340, 1999 | 508 | 1999 |
Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4 KM Beeh, O Kornmann, R Buhl, SV Culpitt, MA Giembycz, PJ Barnes Chest 123 (4), 1240-1247, 2003 | 388 | 2003 |
Delayed eosinophil apoptosis in asthma H Kankaanranta, MA Lindsay, MA Giembycz, X Zhang, E Moilanen, ... Journal of Allergy and Clinical Immunology 106 (1), 77-83, 2000 | 276 | 2000 |
Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T‐lymphocytes: role in regulating proliferation and the biosynthesis of … MA Giembycz, CJ Corrigan, J Seybold, R Newton, PJ Barnes British journal of pharmacology 118 (8), 1945-1958, 1996 | 257 | 1996 |
Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages AJ Thorley, PA Ford, MA Giembycz, P Goldstraw, A Young, TD Tetley The journal of immunology 178 (1), 463-473, 2007 | 256 | 2007 |
Protein kinase C isoenzymes: a review of their structure, regulation and role in regulating airways smooth muscle tone and mitogenesis BLJ Webb, SJ Hirst, MA Giembycz British journal of pharmacology 130 (7), 1433, 2000 | 220 | 2000 |
Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here? MA Giembycz Drugs 59, 193-212, 2000 | 213 | 2000 |
Beyond the dogma: novel β2-adrenoceptor signalling in the airways MA Giembycz, R Newton European Respiratory Journal 27 (6), 1286-1306, 2006 | 203 | 2006 |
Prostanoid receptor antagonists: development strategies and therapeutic applications RL Jones, MA Giembycz, DF Woodward British journal of pharmacology 158 (1), 104-145, 2009 | 201 | 2009 |
Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD MA Giembycz, SK Field Drug design, development and therapy, 147-158, 2010 | 194 | 2010 |
Long-acting β2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells M Kaur, JE Chivers, MA Giembycz, R Newton Molecular pharmacology 73 (1), 203-214, 2008 | 193 | 2008 |
Discovery of BRL 50481 [3-(N, N-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages … SJ Smith, LB Cieslinski, R Newton, LE Donnelly, PS Fenwick, ... Molecular pharmacology 66 (6), 1679-1689, 2004 | 189 | 2004 |
Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with … PM Seldon, PJ Barnes, K Meja, MA Giembycz Molecular Pharmacology 48 (4), 747-757, 1995 | 169 | 1995 |
Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan‐stimulated respiratory burst by ‘type IV’‐selective PDE inhibitors G Dent, MA Giembycz, KF Rabe, PJ Barnes British journal of pharmacology 103 (2), 1339-1346, 1991 | 164 | 1991 |
Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease MA Giembycz Expert opinion on investigational drugs 10 (7), 1361-1379, 2001 | 163 | 2001 |
Release of granulocyte‐macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone MA Saunders, JA Mitchell, PM Seldon, MH Yacoub, PJ Barnes, ... British journal of pharmacology 120 (4), 545-546, 1997 | 163 | 1997 |
A Holy Grail of asthma management: toward understanding how long‐acting β2‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids MA Giembycz, M Kaur, R Leigh, R Newton British journal of pharmacology 153 (6), 1090-1104, 2008 | 159 | 2008 |